Norvasc®
Amlodipine is a long-acting dihydropyridine calcium channel blocker for hypertension and angina. Provides smooth, 24-hour blood pressure reduction.
| Dosage Form | Oral Tablet |
| Strength | 2.5 mg, 5 mg, 10 mg |
| Storage | Store at 15–30°C. |
| Category | Cardiovascular |
| Availability | Available for Transfer |
Hypertension; chronic stable angina; vasospastic (Prinzmetal's) angina; confirmed or suspected CAD (to reduce risk of hospitalization).
Inhibits calcium ion influx through L-type calcium channels in vascular smooth muscle and myocardium. Causes peripheral arterial vasodilation, reducing peripheral resistance and blood pressure.
Each Burrard Pharmaceuticals technology transfer package for Amlodipine includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier templates — available through Burrard Intelligence subscription.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Our team can deliver the complete know-how package within 2–21 business days. Book a consultation to discuss your specific requirements.